Related Experiment Video
Updated: May 16, 2025

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Use of nicotine products and withdrawal support among personnel of the Finnish Defence Forces
Maria Danielsson1,2, A Lammi3, P Sandström3
1Department of Public Health, University of Helsinki, Helsinki, Finland maria.danielsson@helsinki.fi.
Introduction:
While the health hazards of smoking are well known, the harmful effects of smokeless tobacco (snus) and other nicotine products remain less familiar. This study investigates the prevalence and habits of tobacco use among Finnish Defence Forces (FDF) personnel, focusing on the use of snus and preferred withdrawal support.
Methods:
An electronic questionnaire survey was conducted among FDF personnel in 2014 and 2020. The response rates were 18% in 2014 (n=2386) and 27% in 2020 (n=3373). The study examined demographic factors, smoking, snus and e-cigarette use, and preferences for withdrawal support.
Results:
Daily smoking decreased significantly from 14% in 2014 to 6% in 2020, while daily snus use increased from 8% to 11%. E-cigarette use remained low (<1% in 2020). The highest prevalence of snus use was among military personnel working with conscripts. About a quarter of snus users (27%) used snus with a nicotine content of 11-20 mg/g and 30% used snus with a nicotine content of 21-30 mg/g. Preferred withdrawal support included nicotine replacement therapy or medication provided by the employer. A significant number of both smokers and snus users did not receive advice to quit from healthcare professionals.
Conclusions:
Tobacco use among FDF personnel shows a decrease in smoking but an increase in snus use. There is a need for targeted cessation support programmes, with an emphasis on professional advice and employer-provided nicotine replacement therapy. Increased involvement of healthcare professionals in advising quitting could significantly enhance cessation rates.
More Related Videos
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena